摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-methoxy-2-(4-methoxyphenyl)-3-[4(N-methyl-N-2-(piperidin-1-yl)ethylamino)benzoyl]benzo[b]thiophene | 206434-71-1

中文名称
——
中文别名
——
英文名称
6-methoxy-2-(4-methoxyphenyl)-3-[4(N-methyl-N-2-(piperidin-1-yl)ethylamino)benzoyl]benzo[b]thiophene
英文别名
[6-Methoxy-2-(4-methoxyphenyl)-1-benzothiophen-3-yl]-[4-[methyl(2-piperidin-1-ylethyl)amino]phenyl]methanone
6-methoxy-2-(4-methoxyphenyl)-3-[4(N-methyl-N-2-(piperidin-1-yl)ethylamino)benzoyl]benzo[b]thiophene化学式
CAS
206434-71-1
化学式
C31H34N2O3S
mdl
——
分子量
514.689
InChiKey
GSYQSGVXDFPEEH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.9
  • 重原子数:
    37
  • 可旋转键数:
    9
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.32
  • 拓扑面积:
    70.2
  • 氢给体数:
    0
  • 氢受体数:
    6

反应信息

  • 作为反应物:
    描述:
    6-methoxy-2-(4-methoxyphenyl)-3-[4(N-methyl-N-2-(piperidin-1-yl)ethylamino)benzoyl]benzo[b]thiophene三溴化硼 作用下, 以38%的产率得到6-hydroxy-2-(4-hydroxyphenyl)-3-[4-(N-methyl-N-2-(piperidin-1-yl)ethylamino)benzoyl]-benzo[b]thiophene
    参考文献:
    名称:
    Novel nonsteroidal selective estrogen receptor modulators. Carbon and heteroatom replacement of oxygen in the ethoxypiperidine region of raloxifene
    摘要:
    Compounds were synthesized where oxygen in the ethoxypiperidine region of raloxifene is replaced with carbon, sulfur, or nitrogen linkages. Thia- and aza-substituted compounds were prepared by novel methodology. The compounds were evaluated in vitro as selective estrogen receptor modulators (SERMs). Calculations suggested the compounds exhibit an ER-a binding affinity/conformational energy relationship. (C) 1999 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(99)00050-5
  • 作为产物:
    参考文献:
    名称:
    Novel nonsteroidal selective estrogen receptor modulators. Carbon and heteroatom replacement of oxygen in the ethoxypiperidine region of raloxifene
    摘要:
    Compounds were synthesized where oxygen in the ethoxypiperidine region of raloxifene is replaced with carbon, sulfur, or nitrogen linkages. Thia- and aza-substituted compounds were prepared by novel methodology. The compounds were evaluated in vitro as selective estrogen receptor modulators (SERMs). Calculations suggested the compounds exhibit an ER-a binding affinity/conformational energy relationship. (C) 1999 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(99)00050-5
点击查看最新优质反应信息

文献信息

  • Substituted benzo(b)thiophene compounds having activity as selective estrogen receptor modulators
    申请人:ELI LILLY AND COMPANY
    公开号:EP0838464A1
    公开(公告)日:1998-04-29
    The present invention provides compounds with nitrogen, sulfur or carbon linked basic side chains of formula where R1 and R2 are independently hydrogen, halo, hydroxy, alkoxy, alkylcarbonyloxy, alkoxycarbonyl, alkoxycarbonyloxy, arylcarbonyloxy, aryloxycarbonyloxy, or alkylsulfonyloxy; O-SO2-(C4-C6 alkyl), chloro, fluoro, or bromo; W is CHOH, C(O), or CH2; Y is -CH2-, -NH-, -NMe-, -S-, -SO2-; and R3 and R4 are independently hydrogen, alkyl, alkylcarbonyl, alkylamino-carbonyl, or arylcarbonyl, or together with the nitrogen to which they are attached form 1-pyrrolidinyl, 1-piperidinyl, or a 5- or 6-membered imide or cyclic amide ring. The present invention also provides pharmaceutical compositions containing the compounds optionally containing estrogen or progestin, and the use of such compounds, alone, or in combination with estrogen or progestin, for treating osteoporosis, aortal smooth muscle cell proliferation, (particularly restenosis), and estrogen-dependent cancer (particularly breast cancer).
    本发明提供了具有氮、或碳连接的基本侧链的化合物,其式如下 其中 R1 和 R2 独立地是氢、卤素、羟基、烷氧基、烷基羰基氧基、烷氧基羰基氧基、烷氧基羰基氧基、芳基羰基氧基、芳基氧基羰基氧基或烷基磺酰氧基;O-SO2-(C4-C6 烷基)、;W 是 CHOH、C(O) 或 CH2;Y 是- -、-NH-、-NMe-、-S-、-SO2-;R3 和 R4 独立地是氢、烷基、烷基羰基、烷基基羰基或芳基羰基,或与它们所连接的氮一起形成 1-吡咯烷基、1-哌啶基或 5 或 6 元亚胺或环酰胺环。 本发明还提供了含有可选地含有雌激素或孕激素的化合物的药物组合物,以及这些化合物单独或与雌激素或孕激素联合用于治疗骨质疏松症、动脉平滑肌细胞增殖(特别是再狭窄)和雌激素依赖性癌症(特别是乳腺癌)的用途。
  • US5962475A
    申请人:——
    公开号:US5962475A
    公开(公告)日:1999-10-05
查看更多